Comprehensive Stock Analysis of: Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) will report its next earnings on 18-Oct-16. The company reported the earnings of $1.74/Share in the last quarter where the estimated EPS by analysts was $1.68/share. The difference between the expected and actual EPS was $0.06/share, which represents an Earnings surprise of 3.6%.

Many analysts are providing their Estimated Earnings analysis for Johnson & Johnson and for the current quarter 19 analysts have projected that the stock could give an Average Earnings estimate of $1.65/share. These analysts have also projected a Low Estimate of $1.59/share and a High Estimate of $1.75/share.

In case of Revenue Estimates, 19 analysts have provided their consensus Average Revenue Estimates for Johnson & Johnson as 17.74 Billion. According to these analysts, the Low Revenue Estimate for Johnson & Johnson is 17.52 Billion and the High Revenue Estimate is 17.98 Billion. The company had Year Ago Sales of 17.1 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for JNJ to be 10.7%. They are projecting Next Quarter growth of 9.7%. For the next 5 years, Johnson & Johnson is expecting Growth of 6.52% per annum, whereas in the past 5 years the growth was 6.33% per annum.

Some buy side analysts are also providing their Analysis on Johnson & Johnson, where 3 analysts have rated the stock as Strong buy, 7 analysts have given a Buy signal, 13 said it’s a HOLD, 0 reported it as Underperform and 1 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 20 Analysts reported that the Price Target for Johnson & Johnson might touch $142 high while the Average Price Target and Low price Target is $124.5 and $81 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Johnson & Johnson got Initiated on 20-May-16 where investment firm Standpoint Research Initiated the stock to Sell.

Johnson & Johnson closed its last trading session at $118.49 with the loss of -2.6%. The Market Capitalization of the company stands at 317.63 Billion. The Company has 52-week high of $126.07 and 52-week low of $94.28. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -2.67% where SMA50 and SMA200 are -3.25% and 2.84% respectively. The Company Touched its 52-Week High on Jul 20, 2016 and 52-Week Low on Jan 21, 2016.

The Relative Volume of the company is 2.08 and Average Volume (3 months) is 6.06 million. Johnson & Johnson P/E (price to earnings) ratio is 21.5 and Forward P/E ratio of 16.23.

The company shows its Return on Assets (ROA) value of 11.1%. The Return on Equity (ROE) value stands at 20.9%. While it’s Return on Investment (ROI) value is 14.7%.

While looking at the Stock’s Performance, Johnson & Johnson currently shows a Weekly Performance of -1.9%, where Monthly Performance is -1.91%, Quarterly performance is -7.16%, 6 Months performance is 3.02% and yearly performance percentage is 21.22%. Year to Date performance value (YTD perf) value is 14.74%. The Stock currently has a Weekly Volatility of 1.45% and Monthly Volatility of 1.12%.